Msci Inc vs Oscar Health Inc — how do they compare? Msci Inc trades at $565.12 (market cap $40.38B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Msci Inc is far larger — about 4× Oscar Health Inc's market cap, and Msci Inc pays a 1.48% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Msci Inc for 82 Days and Oscar Health Inc for 15 Days on average.
| MSCI | OSCR | |
|---|---|---|
Market Cap | $40.38B | $10.22B |
Volume | 414,140 | 4,123,394 |
Sector | Financials | Health |
52-Week High | $643.83 | $33.81 |
52-Week Low | $511.84 | $10.85 |
Typical Hold Time | 82 Days | 15 Days |
Enterprise Value | $46.54B | $6.57B |
Dividend Yield | 1.48% | — |
Signals from Pluang's Aura AI — not financial advice
MSCI trades at $561.67, up 1.13% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent revenue growth, reaching $3.13B in 2025, with a high net income margin of 40.73%. Recent earnings have mostly beaten expectations, and the company maintains robust cash flow from operations. Analyst consensus is strongly positive, with a $701.71 price target, supported by 74% buy ratings. Key developments include the completed acquisition of First Street, enhancing its climate risk analytics offerings.
The outlook for MSCI is favorable, driven by recurring revenue streams, high client retention, and growth in passive investing and private markets. Risks include high valuation multiples, significant long-term debt of $4.51B, and sensitivity to financial market cycles. The stock presents a long-term growth opportunity, but investors should monitor execution on earnings and debt management.
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Read more on MSCI →Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →